Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History FHTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics FHTX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Foghorn Therapeutics Inc

FHTX
Current price
4.89 USD +0.17 USD (+3.60%)
Last closed 4.72 USD
ISIN US3441741077
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 263 099 392 USD
Yield for 12 month -8.08 %
1Y
3Y
5Y
10Y
15Y
FHTX
21.11.2021 - 28.11.2021

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is also developing therapies for mutant cancers, such as androgen receptor, positive prostate cancer, bladder cancer, Non-Small Cell Lung (NSCLC), as well as various lymphomas and leukemias; melanoma, endometrial, gastric, breast, colorectal, and pancreatic cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 500 Technology Square, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.57 USD

P/E ratio

Dividend Yield

Financials FHTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures FHTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+22 602 000 USD

Last Year

+34 155 000 USD

Current Quarter

+5 952 000 USD

Last Quarter

+2 856 000 USD

Current Year

+22 602 000 USD

Last Year

-75 534 000 USD

Current Quarter

+5 952 000 USD

Last Quarter

+2 856 000 USD
EBITDA -91 892 000 USD
Operating Margin TTM -384.96 %
Price to Earnings
Return On Assets TTM -23.12 %
PEG Ratio
Return On Equity TTM -470.38 %
Wall Street Target Price 10.57 USD
Revenue TTM 23 504 000 USD
Book Value -1.11 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17.90 %
Dividend Yield
Gross Profit TTM -67 116 000 USD
Earnings per share -1.29 USD
Diluted Eps TTM -1.29 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation FHTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.36
Price Sales TTM 11.27
Enterprise Value EBITDA -1.21
Price Book MRQ 10.71

Technical indicators FHTX

For 52 weeks

2.94 USD 10.25 USD
50 Day MA 4.20 USD
Shares Short Prior Month 1 068 995
200 Day MA 5.76 USD
Short Ratio 8.54
Shares Short 1 098 998
Short Percent 3.00 %